Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00849199 · ClinicalTrials.gov registry record
Cancer Screening and Prevention Program for High Risk Women
A clinical trial of Breast Cancer and Ovarian Cancer, sponsored by NYU Langone Health.
- Completed
- Registry status
- 1,452
- Enrollment target
- 3
- Study locations
NCT00849199: Completed study of Breast Cancer and Ovarian Cancer, sponsored by NYU Langone Health.
NCT00849199 is a study of Breast Cancer and Ovarian Cancer that has completed, run by NYU Langone Health. The registered enrollment target is 1,452 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (48% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00849199, a study of Breast Cancer and Ovarian Cancer, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 1,452 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to collect information from a large group of women who may have a greater chance to develop cancer because of their own personal history of cancer or because of their family history of cancer.
Conditions Studied
Study Locations (3)
New York
- Bellevue Hospital - New York
- NYU Cancer Center - New York
- NYU Tisch Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,452 participants |
| Start Date | 2001-07 |
| Est. Completion | 2018-01 |
What the finished NCT00849199 record still lists
NCT00849199 is an observational study that tracks outcomes without assigning an intervention. Its 1,452 participants enrollment target places it among the larger protocols in the corpus, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (48% lower).
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00849199 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00849199 about?
NCT00849199 is a clinical study titled "Cancer Screening and Prevention Program for High Risk Women". The purpose of this study is to collect information from a large group of women who may have a greater chance to develop cancer because of their own personal history of cancer or because of their family history of cancer.
What is the current status of trial NCT00849199?
This trial is currently completed. The enrollment target is 1,452 participants. The study started on 2001-07. Estimated completion is 2018-01.
What conditions does trial NCT00849199 study?
This clinical trial studies the following conditions: Breast Cancer, Ovarian Cancer.
Who is sponsoring clinical trial NCT00849199?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00849199 being conducted?
This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00849199's enrollment target sits among peer trials
1,452 86th of 1224 higher than 1,139 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06782347 · 1,454 participants · NA
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
- NCT04566328 · 1,450 participants · Phase 3
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- NCT05229341 · 1,450 participants · NA
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
- NCT05910268 · 1,450 participants · NA
Peru Decentralized HIV Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia